WallStreetZenWallStreetZen

NASDAQ: XGN
Exagen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for XGN

Based on 4 analysts offering 12 month price targets for Exagen Inc

Min Forecast
$8.00+108.88%
Avg Forecast
$13.25+245.95%
Max Forecast
$15.00+291.64%

Should I buy or sell XGN stock?

Based on 4 analysts offering ratings for Exagen Inc.

Strong Buy
Strong Buy
4 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although XGN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates XGN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their XGN stock forecasts and price targets.

XGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-30
lockedlocked$00.00+00.00%2025-11-10Find Out Why
lockedlocked$00.00+00.00%2025-10-27
lockedlocked$00.00+00.00%2025-10-14

1 of 1

Forecast return on equity

Is XGN forecast to generate an efficient return?

Company
7.57%
Industry
13.92%
Market
213.28%
XGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is XGN forecast to generate an efficient return on assets?

Company
2.19%
Industry
16.7%
XGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

XGN earnings per share forecast

What is XGN's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$0.47
Avg 2 year Forecast
-$0.27
Avg 3 year Forecast
-$0.01

XGN revenue forecast

What is XGN's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$77.6M+21.94%
Avg 2 year Forecast
$87.6M+37.74%
Avg 3 year Forecast
$101.4M+59.44%
XGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XGN revenue growth forecast

How is XGN forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
16.35%
Industry
7.88%
Market
23.15%
XGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XGN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
XGN$3.83$13.25+245.95%Strong Buy
BDSX$10.29$20.00+94.36%Strong Buy
DRIO$10.94N/AN/A
SERA$2.78N/AN/A
FONR$18.62N/AN/A
View Top Diagnostic & Research Stocks

Exagen Stock Forecast FAQ

Is Exagen Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: XGN) stock is to Strong Buy XGN stock.

Out of 4 analysts, 4 (100%) are recommending XGN as a Strong Buy, 0 (0%) are recommending XGN as a Buy, 0 (0%) are recommending XGN as a Hold, 0 (0%) are recommending XGN as a Sell, and 0 (0%) are recommending XGN as a Strong Sell.

If you're new to stock investing, here's how to buy Exagen stock.

What is XGN's earnings growth forecast for 2026-2028?

(NASDAQ: XGN) Exagen's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 19.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.9%.

Exagen's earnings in 2026 is -$19,039,000.On average, 9 Wall Street analysts forecast XGN's earnings for 2026 to be -$10,728,711, with the lowest XGN earnings forecast at -$19,988,853, and the highest XGN earnings forecast at -$6,900,914. On average, 7 Wall Street analysts forecast XGN's earnings for 2027 to be -$6,180,227, with the lowest XGN earnings forecast at -$15,102,689, and the highest XGN earnings forecast at -$475,925.

In 2028, XGN is forecast to generate -$115,582 in earnings, with the lowest earnings forecast at -$2,887,279 and the highest earnings forecast at $2,855,550.

What is XGN's revenue growth forecast for 2026-2028?

(NASDAQ: XGN) Exagen's forecast annual revenue growth rate of 16.35% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.15%.

Exagen's revenue in 2026 is $63,599,000.On average, 9 Wall Street analysts forecast XGN's revenue for 2026 to be $1,757,613,980, with the lowest XGN revenue forecast at $1,636,864,988, and the highest XGN revenue forecast at $1,929,876,195. On average, 7 Wall Street analysts forecast XGN's revenue for 2027 to be $1,985,310,135, with the lowest XGN revenue forecast at $1,865,626,310, and the highest XGN revenue forecast at $2,191,634,989.

In 2028, XGN is forecast to generate $2,298,038,239 in revenue, with the lowest revenue forecast at $2,152,133,207 and the highest revenue forecast at $2,472,544,101.

What is XGN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: XGN) forecast ROA is 2.19%, which is lower than the forecast US Diagnostics & Research industry average of 16.7%.

What is XGN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year XGN price target, the average XGN price target is $13.25, with the highest XGN stock price forecast at $15.00 and the lowest XGN stock price forecast at $8.00.

On average, Wall Street analysts predict that Exagen's share price could reach $13.25 by Jan 30, 2027. The average Exagen stock price prediction forecasts a potential upside of 245.95% from the current XGN share price of $3.83.

What is XGN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: XGN) Exagen's current Earnings Per Share (EPS) is -$0.92. On average, analysts forecast that XGN's EPS will be -$0.47 for 2026, with the lowest EPS forecast at -$0.88, and the highest EPS forecast at -$0.30. On average, analysts forecast that XGN's EPS will be -$0.27 for 2027, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.02. In 2028, XGN's EPS is forecast to hit -$0.01 (min: -$0.13, max: $0.13).

What is XGN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: XGN) forecast ROE is 7.57%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.